Pluri Share Price
NASDAQ: PLUR | HealthcarePluri Stock Performance
Pluri Share Price Chart
Pluri Quarterly Profit & Loss
All figures in USD
Pluri Annual Profit & Loss
All figures in USD
Pluri Balance Sheet
All figures in USD Million
Pluri Cash Flow
All figures in USD Million
Corporate Actions
About Pluri
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Pluri Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.24 | $1.01 | -17.89% |
Oct 2026 | $0.87 | $1.23 | +16.04% |
Sep 2026 | $1.29 | $1.06 | -29.33% |
Aug 2026 | $1.83 | $1.50 | -3.23% |
Jul 2026 | $2.19 | $1.55 | -28.24% |
Jun 2026 | $2.47 | $2.16 | -14.46% |
May 2026 | $3.40 | $2.52 | -24.63% |
Apr 2026 | $3.38 | $3.35 | +9.12% |
Mar 2026 | $3.71 | $3.07 | -16.58% |
Feb 2026 | $3.35 | $3.68 | +8.55% |
Jan 2026 | $3.02 | $3.39 | +12.62% |
Dec 2025 | $3.50 | $3.01 | -20.58% |